Skip to content

Pharmaceutical Literacy and Quality of Life in Spanish Population.

Pharmaceutical Literacy in Spanish Population and Association With Health-Related Quality of Life

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06729697
Enrollment
1246
Registered
2024-12-11
Start date
2024-11-15
Completion date
2025-07-30
Last updated
2025-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Related Quality of Life, Literacy

Keywords

Pharmaceutical literacy, Health related quality of life, Spain, Community pharmacist

Brief summary

The goal of this study is to learn about the knowledge and abilities that patients have regarding their own medication and to see if that's related to their quality of life. The main questions it aims to answer are: * Are patients abilities and knowledge about their medications sufficient to ensure a safe and efective use? * Are those knowledge and abilities related to the patient's quality of life? How? Patients already taking at least one medication will answer questions about their abilities and knowledge towards medication and their quality of life related to their health state.

Detailed description

A cross-sectional study is carried out, consisting of an interview between the patients and community pharmacists included in the study. The participants selected are adults usually taking medication that answer questions related to their pharmaceutical literacy (RALPH interview). This type of literacy refers to three domains regarding functional, comunicative and critical abilities about their own medication. After that, every participant answers a simple survey regarding their health-related quality of life including topics such as mobility, self-care, everyday activities, pain and mental health (EQ-5D-5L survey). The recruitment and interviewing take place at the same time, and it requires less than 30 minutes per patient. No follow-up is needed afterward. There are no risks associated with this procedure, and the participation of the patients will always be voluntary and anonymous. Previously to the patients' enrollment in the study, proper information will be given to the potential participants and an informed consent will be signed.

Interventions

None listed

Sponsors

Sociedad Espanola de Farmacia Clinica, Familiar y Comunitaria
CollaboratorOTHER
University of Barcelona
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults currently taking at least one medication prescribed by a physician and living in Spain.

Exclusion criteria

* Having physical or cognitive limitations that make it impossible to answer the study questions.

Design outcomes

Primary

MeasureTime frameDescription
Recognising and Addressing Limited Pharmaceutical Literacy (RALPH) interview guide scoreThrough study completion, an average of 1 year.A quantitative score will be obtained after an interview using the RALPH guide for community pharmacy. Only correct answered questions will add a point to the score. The values obtained stand between 0 and 10, and a higher score means a better outcome.
EQ-5D-5L index scoreThrough study completion, an average of 1 year.A health state index score will be calculated from individual health profiles using the Spanish value set (Roudijk B, Ludwig K, Devlin N, Roudijk B, Ludwig K, Devlin N. EQ-5D-5L Value Set Summaries. Value Sets for EQ-5D-5L. 2022;55-212.) where the values stand between -0.166 and 1, and a higher score means a better outcome.

Secondary

MeasureTime frameDescription
Country of birthThrough study completion, an average of 1 year.Name of the country of birth.
Level of educationThrough study completion, an average of 1 year.Education level according to the 4 categories: uneducated, primary education, secondary education and higher education.
Situation related to economic activityThrough study completion, an average of 1 year.Economic activity according to the 7 categories: working, unemployed, retired, studying, unable to work, mainly engaged in housework and other situations.
SexThrough study completion, an average of 1 year.Sex according to the categories: male or female.
Time since the prescription of the medicineThrough study completion, an average of 1 year.Time in months.
Total number of medicines prescribed per dayThrough study completion, an average of 1 year.Number of medicines prescribed per day according to the categories: less than 5 medicines and more than 5.
Working timeThrough study completion, an average of 1 year.If working, type of working time according to the categories: full time and part time.
AgeThrough study completion, an average of 1 year.Age in years.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026